Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03837119

Enrollment

540

Registered

2019-02-11

Start date

2018-04-04

Completion date

2021-04-11

Last updated

2024-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heterozygous Haemoglobinopathy

Keywords

pregnancy, gestational diabetes, cholestasis in pregnancy, urinary tract infection in pregnancy

Brief summary

This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze if there are aggravated maternal and/or perinatal risks.

Interventions

OTHERpregnancy outcome

descriptive statistics of variables

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* pregnant women with or without heterozygous hemoglobinopathy

Exclusion criteria

* refusal of study participation

Design outcomes

Primary

Measure	Time frame	Description
urinary tract infection	in the course of pregnancy until delivery	number of women developing urinary tract infection
gestational diabetes	in the course of pregnancy until delivery	number of women developing gestational diabetes in pregnancy
cholestasis in pregnancy	in the course of pregnancy until delivery	number of women developing cholestasis in pregnancy

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026